Why would you risk taking ‘Fauxzempic’?
The IndependentOver the past two years, there has only been one word worth knowing about weight loss: Ozempic. When used as a slimming tool, the drug has become so in demand as to trigger global shortages; it’s made its manufacturers, Novo Nordisk, Europe’s most valuable company, and has gone from Hollywood’s “dirty little secret” to a status symbol among those no longer forced to suffer the indignity of sweating off unwanted pounds. This week, a global alert has been issued for counterfeit versions of the “skinny jab” – but it’s far from the first time dangerous versions have been found. Add those to the “thousands” of dodgy pens found in the US, across Brazil and Lebanon, Serbia and Belgium, the rising overweight and obesity levels that now affect two-thirds of UK adults, and the fact we’re all now primed to expect instant gratification, and the outlook becomes even more alarming. Last week, the NHS’s medical director spoke out about the number of “otherwise healthy” users ending up in A&E due to complications from taking the drug without a medical need.